Abvc Biopharma ABVC
NASDAQ ABVC
$0.90 -0.08 (-8.16%)
At close: Nov 13, 2026 · 4:00 PM EST

Abvc Biopharma (ABVC) Equity Income (2024 - 2026)

Updated

Abvc Biopharma (ABVC) posted Equity Income of -$31,416 for Q1 2026, compared with -$50,877 a year earlier.

Analysis

Abvc Biopharma (ABVC) Equity Income (2024 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Equity Income at Abvc Biopharma was -$783,547; for FY2025, it came in at -$803,008.

  • In prior years, Abvc Biopharma's Equity Income was -$339,171 in FY2024.
  • The Q1 2026 figure stands as the highest quarterly Equity Income in data going back to Q2 2024.
  • According to Business Quant data, Equity Income for the three prior quarters was -$652,979 (Q4 2025), -$54,235 (Q3 2025) and -$44,917 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -19.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Abvc Biopharma 24.28 Mn 21.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -31,416.00
Dec 31, 2025 -652,979.00
Sep 30, 2025 -54,235.00
Jun 30, 2025 -44,917.00
Mar 31, 2025 -50,877.00
Dec 31, 2024 -192,229.00
Sep 30, 2024 -67,885.00
Jun 30, 2024 -79,057.00
API Access

Abvc Biopharma Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ABVC&period=max&api_key=YOUR_API_KEY